Involvement of the platelet-activating factor receptor in host defense against<i>Streptococcus pneumoniae</i>during postinfluenza pneumonia

Koenraad F. van der Sluijs, Leontine J. R. van Elden, Monique Nijhuis, Rob Schuurman, Sandrine Florquin, Takao Shimizu, Satoshi Ishii, Henk M. Jansen, René Lutter, Tom van der Poll

American Journal of Physiology-Lung Cellular and Molecular Physiology · 2005 · 95 citations · 30 references

Concepts

Abstract

Although influenza infection alone may lead to pneumonia, secondary bacterial infections are a much more common cause of pneumonia. Streptococcus pneumoniae is the most frequently isolated causative pathogen during postinfluenza pneumonia. Considering that S. pneumoniae utilizes the platelet-activating factor receptor (PAFR) to invade the respiratory epithelium and that the PAFR is upregulated during viral infection, we here used PAFR gene-deficient (PAFR-/-) mice to determine the role of this receptor during postinfluenza pneumococcal pneumonia. Viral clearance was similar in wild-type and PAFR-/- mice, and influenza virus was completely removed from the lungs at the time mice were inoculated with S. pneumoniae (day 14 after influenza infection). PAFR-/- mice displayed a significantly reduced bacterial outgrowth in their lungs, a diminished dissemination of the infection, and a prolonged survival. Pulmonary levels of IL-10 and KC were significantly lower in PAFR-/- mice, whereas IL-6 and TNF-alpha were only trendwise lower. These data indicate that the pneumococcus uses the PAFR leading to severe pneumonia in a host previously exposed to influenza A.

References

30